고순도 구연산 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the high-purity citric acid market size is expected to increase from USD 0.55 billion in 2025 to USD 0.61 billion in 2026 and reach USD 0.82 billion by 2031, growing at a CAGR of 7.2% over 2026-2031.

This report is Segmented by Purity Grade (Pharma Grade, Food Grade, and Industrial Grade), Form (Powder/Crystalline and Liquid), Application (Food and Beverages, Pharmaceuticals, Cosmetics and Personal Care, Analytical and Laboratory Use, and Others), and Geography (North America, Europe, Asia-Pacific, South America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global High-Purity Citric Acid Market Trends and Insights

Growing Use in Pharmaceutical Excipients and Oral Drug Formulations

In the pharmaceutical industry, citric acid has transitioned from being merely an acidulant to serving a broader range of critical functions. It is now widely utilized as a chelating agent, effectively protecting sensitive active ingredients in tablets, syrups, and oral liquid formulations from degradation caused by metal ions. This expanded role highlights its importance in ensuring the stability and efficacy of drug products. Additionally, major regulated markets mandate the use of USP and EP-compliant materials in pharmaceutical filings, creating a clear distinction between certified high-purity supplies and lower-grade alternatives. The high-purity citric acid market is also experiencing growth due to its application in reformulating low-solubility drugs. Citrate-based systems are increasingly employed to enhance bioavailability, addressing a key challenge in drug development. This dual capability of supporting regulatory compliance and improving formulation performance ensures a steady and durable demand for high-purity citric acid in the pharmaceutical sector.

Rising Use in Biotechnology Fermentation Media and Cell Culture Applications

Biotechnology processes, which depend on tightly controlled raw materials, play a significant role in driving the high purity citric acid market. In fermentation media and cell culture systems, citric acid performs multiple critical functions, including serving as a carbon source, acting as a chelation aid, and stabilizing pH levels. This multifunctionality reduces the likelihood of substitution, as maintaining process consistency is as crucial as managing costs in both upstream and downstream biologics operations. Furthermore, ongoing research into non-conventional yeasts and advancements in organic acid bioproduction are expanding the range of systems that can effectively utilize citrate-based supplementation. As a result, the high purity citric acid market continues to benefit from the rapid expansion of the biotechnology sector, even in scenarios where commodity citric acid prices remain under pressure.

High Production and Purification Costs

Producing high-purity citric acid involves high costs due to the stringent requirements for pharmaceutical and premium food grades. These grades necessitate advanced processes such as multi-stage crystallization, ion exchange purification, and comprehensive heavy metals testing, all of which substantially increase production expenses compared to lower-grade citric acid. Producers outside China often face additional challenges, including higher structural costs stemming from weaker feedstock integration, elevated energy expenses, and stricter compliance requirements. Consequently, the market increasingly favors larger, integrated suppliers capable of spreading purification and testing costs across higher production volumes, thereby achieving greater cost efficiency. Although smaller players can still compete in niche segments, their ability to influence pricing is progressively determined by their scale of operations and the breadth of their certifications, which are becoming critical factors in maintaining competitiveness.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing Use in Premium Confectionery and Sugar-Free Candies
2. Growing Use in Effervescent Tablets and Powders
3. Supply Chain Disruptions for Feedstocks

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Pharma Grade held 51.38% of the market in 2025, which made it the largest purity segment in the high-purity citric acid market. This position reflects the fact that regulated drug products require material aligned with USP, EP, JP, or similar standards, which keeps demand relatively captive. The high-purity citric acid market continues to rely on pharmaceutical use as an anchor because excipient performance and compliance are both essential in oral and parenteral formulations. Suppliers with multi-compendial certification hold an advantage because they reduce qualification complexity for global buyers.

Food Grade is projected to grow at an 8.68% CAGR from 2026 to 2031, which makes it the fastest-growing purity segment in the high-purity citric acid market. This rise does not weaken the pharmaceutical premium because much of the momentum comes from applications such as infant formula, clinical nutrition, and nutraceutical products, where specification standards are also strict. The high-purity citric acid industry is therefore seeing more overlap between advanced food applications and pharma-linked quality expectations. Industrial Grade remains smaller within this report's scope because its end uses are less sensitive to the purity and documentation requirements that define premium demand. The segment mix shows that volume growth is broadening, while value capture still depends heavily on certification depth.

Complete Report Scope:

• By Purity Grade
  • Pharma Grade
  • Food Grade
  • Industrial Grade
• By Form
  • Powder/Crystalline
  • Liquid
• By Application
  • Food and Beverages
  • Pharmaceuticals
  • Cosmetics and Personal Care
  • Analytical and Laboratory Use
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific held 42.64% of the market in 2025, giving it the leading position in the high-purity citric acid market. The region combines large-scale fermentation capacity with strong downstream demand from pharmaceuticals and food processing. China remains central because its production system benefits from feedstock access, fermentation scale, and integrated manufacturing structures that support cost efficiency. India strengthens the regional demand picture through its large pharmaceutical formulation base and continuing need for certified excipients in regulated products. The high-purity citric acid market in Asia-Pacific therefore reflects both production strength and expanding local consumption.

Europe is projected to grow at an 8.15% CAGR from 2026 to 2031, making it the fastest-growing regional segment in the high-purity citric acid market. Demand is being supported by pharmaceutical, nutraceutical, premium food, and personal care buyers who value tightly documented supply and certified grades. The region also places a higher premium on dependable sourcing after recent years of freight and supply disruption. The high-purity citric acid market in Europe is therefore growing on quality assurance and sourcing strategy rather than on low cost production.

North America remains an important part of the high purity citric acid market because it has major domestic ingredient producers and a large base of pharmaceutical and food customers. Strategic investment is reshaping the region, as Jungbunzlauer closed its Illinois facility acquisition in 2025 to establish a U.S. manufacturing footprint for premium ingredients. South America and the Middle East and Africa are smaller in current scale, but they continue to add demand through food processing expansion and regional pharmaceutical trade flows. The high purity citric acid market across these regions remains less mature, yet their incremental demand supports a broader global customer base.

1. Jungbunzlauer Suisse AG
2. Cargill, Incorporated
3. Archer Daniels Midland Company
4. COFCO Biotechnology Co., Ltd.
5. TTCA CO., LTD.
6. Shandong Ensign Industry Co., Ltd.
7. Citribel NV
8. Gadot Biochemical Industries Ltd.
9. RZBC Group Co., Ltd.
10. Huangshi Xinghua Biochemical Co., Ltd.
11. Foodchem International Corporation
12. Merck KGaA
13. Brenntag SE
14. Roquette Freres
15. Tate and Lyle PLC
16. Corbion N.V.
17. Xitrical Co., Ltd.
18. ECSA Chemicals AG
19. Hubei Xingfa Chemicals Group Co., Ltd.
20. Jiangsu Guoxin Union Energy Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Use in Pharmaceutical Excipients and Oral Drug Formulations
  • 4.2.2 Rising Use in Biotechnology Fermentation Media and Cell Culture Applications
  • 4.2.3 Increasing Use in Premium Confectionery and Sugar-Free Candies
  • 4.2.4 Growing Use in Effervescent Tablets and Powders
  • 4.2.5 Increasing Demand from Infant Formula and Clinical Nutrition Products
  • 4.2.6 Nutraceutical Gummies and Dietary Supplements Facing Stronger Demand
• 4.3 Market Restraints
  • 4.3.1 High Production and Purification Costs
  • 4.3.2 Supply Chain Disruptions for Feedstocks
  • 4.3.3 Competition from Alternative Acidulants
  • 4.3.4 Stringent Regulatory Compliance Requirements
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Purity Grade
  • 5.1.1 Pharma Grade
  • 5.1.2 Food Grade
  • 5.1.3 Industrial Grade
• 5.2 By Form
  • 5.2.1 Powder/Crystalline
  • 5.2.2 Liquid
• 5.3 By Application
  • 5.3.1 Food and Beverages
  • 5.3.2 Pharmaceuticals
  • 5.3.3 Cosmetics and Personal Care
  • 5.3.4 Analytical and Laboratory Use
  • 5.3.5 Others
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Netherlands
    • 5.4.2.7 Sweden
    • 5.4.2.8 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
  • 5.4.5 Middle East and Africa
    • 5.4.5.1 United Arab Emirates
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Ranking Analysis
• 6.4 Company Profiles (Includes Global-level Overview, Market-level Overview, Core Segments, Financials, Strategic Info, Market Rank/Share, Products & Services, Recent Developments)
  • 6.4.1 Jungbunzlauer Suisse AG
  • 6.4.2 Cargill, Incorporated
  • 6.4.3 Archer Daniels Midland Company
  • 6.4.4 COFCO Biotechnology Co., Ltd.
  • 6.4.5 TTCA CO., LTD.
  • 6.4.6 Shandong Ensign Industry Co., Ltd.
  • 6.4.7 Citribel NV
  • 6.4.8 Gadot Biochemical Industries Ltd.
  • 6.4.9 RZBC Group Co., Ltd.
  • 6.4.10 Huangshi Xinghua Biochemical Co., Ltd.
  • 6.4.11 Foodchem International Corporation
  • 6.4.12 Merck KGaA
  • 6.4.13 Brenntag SE
  • 6.4.14 Roquette Freres
  • 6.4.15 Tate and Lyle PLC
  • 6.4.16 Corbion N.V.
  • 6.4.17 Xitrical Co., Ltd.
  • 6.4.18 ECSA Chemicals AG
  • 6.4.19 Hubei Xingfa Chemicals Group Co., Ltd.
  • 6.4.20 Jiangsu Guoxin Union Energy Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK